StockData
STAAR Surgical Co logo

STAAR Surgical Co (STAA) income statement

STAANasdaqOphthalmic GoodsFiscal year ends January 2
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 3, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3067% above fair value
$25.35−0.21 (-0.82%)

Close on Nov 18, 2026Market cap $1.27BP/E 362.1Yield –

STAAR Surgical Co income statement

Ratios

Latest available, balances at Jul 3, 2026

Profitability, TTM

Gross margin
76.6%
Operating margin
4.0%
Net margin
1.1%
Return on equity, FY2025
-21.7%

Financial strength

Current ratio
4.66
Debt to equity
–
Debt to assets
–
Cash to current liabilities
202.4%

Valuation

P/E ratio
362.1
Price to sales
3.74
Price to book
3.48
Dividend yield
–

See a number that looks wrong?